Workflow

MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI® 4.0 Models

Retrieved on: 
Monday, May 15, 2023
MRT, US Foods, AI, Food and Drug Administration, MIM, FDA, Algorithm, Software, Contour, Workflow, Food, Radiation therapy, Therapy, Medical device

CLEVELAND, May 15, 2023 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced US Food and Drug Administration (FDA) clearance of its newest version of the AI auto-contouring solution Contour ProtégéAI.

Key Points: 
  • CLEVELAND, May 15, 2023 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced US Food and Drug Administration (FDA) clearance of its newest version of the AI auto-contouring solution Contour ProtégéAI.
  • The update provides MIM Software customers with iteratively improved algorithms for Radiation Oncology segmentation, additional structures, and enhancements for Molecular Radiotherapy (MRT).
  • With new FDA-cleared contours and the power of flexible implementation, Contour ProtégéAI can be added to any existing workflow with minimal effort and exceptional contouring results.
  • "Over the past several months, the MIM Software team has worked hard to focus this new version on improving our contouring performance," said Jay Obman, Product Manager at MIM Software Inc. "The initial testing has shown a good improvement in our overall contour quality, and I'm excited for our users to reap the benefits of those improvements as well as some new contours we've added."

Q4 Inc. Announces Solid First Quarter 2023 Results

Retrieved on: 
Monday, May 15, 2023
Professional Services, Communications, Other Professional Services, Technology, Software, Other Communications, Public Relations, Investor Relations, Inc., IR, International, Partnership, Workflow, Marketing, Bank statement, Synthetic media, ARPA, EBITDA, Traction, International Financial Reporting Standards, CRM, SEDAR, Generative, Webcast, TSX, ESG, Q4, Adjustment, Engagement, First Capital Connect, LATAM, Cryptocurrency, Video game, Sales

Q4 Inc. (TSX:QFOR) (“Q4” or the “Company”), a leading capital markets access platform, today announced its financial results for the three-month period ended March 31, 2023.

Key Points: 
  • Q4 Inc. (TSX:QFOR) (“Q4” or the “Company”), a leading capital markets access platform, today announced its financial results for the three-month period ended March 31, 2023.
  • “Over half of our bookings were expansions with existing clients who continue adding new modules to their Q4 stack, such as engagement analytics, CRM and ESG add-ons.
  • “Across the business, we continue pulling on multiple levers to accelerate towards profitable growth,“ said Donna de Winter, Chief Financial Officer.
  • Q4 will host a webcast to discuss the Company's financial results at 9:30 am ET on Monday, May 15, 2023.

New Version of Tridion Unites Web Content, Structured Content and Headless Delivery in Industry First

Retrieved on: 
Monday, May 15, 2023
Professional Services, Data Management, Technology, Software, Finance, Artificial Intelligence, Internet, IDC, Intellectual property, Workflow, Language, Organization, RWS, DXD, Research, Content, Video game, Online shopping, Medical device, Trimethadione, Se Fonto Kokkino

The platform combines web content, structured content and headless delivery in a single solution, making it a game-changer for organizations with heavy content demands.

Key Points: 
  • The platform combines web content, structured content and headless delivery in a single solution, making it a game-changer for organizations with heavy content demands.
  • “Advanced headless delivery for structured content is best way to make business-critical information accessible on the various digital touchpoints that form part of today’s customer experience.
  • “Tridion leads the market in combining multilingual structured content management with web content management capabilities, while simultaneously supporting a transition from unstructured to structured content in many industries.
  • The launch comprises the release of Tridion Docs 15 and Tridion Sites 10 , including an updated version of Tridion Dynamic Experience Delivery (DXD) and a new embedded version of Fonto for structured content authoring.

Introducing JobPlanner: A Powerful Construction Management Software

Retrieved on: 
Saturday, May 13, 2023
Workflow, Software, Construction

SCOTTSDALE, Ariz., May 13, 2023 /PRNewswire-PRWeb/ -- With JobPlanner, construction project managers can easily collaborate with their team members and clients, streamline workflows, and monitor progress in real-time. The software offers a range of features, including scheduling, resource allocation, budget management, task tracking, and reporting.

Key Points: 
  • JobPlanner, a leading software development company, is proud to announce the release of their newest comprehensive construction management software designed to simplify project planning, scheduling, and execution, bringing AI to the job site.
  • The software offers a range of features, including scheduling, resource allocation, budget management, task tracking, and reporting.
  • The software offers a range of features, including scheduling, resource allocation, budget management, task tracking, and reporting.
  • "JobPlanner is a game-changer for construction project management," said DeWayne Adamson, the CEO of JobPlanner.

GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress

Retrieved on: 
Friday, May 12, 2023
Software, Research, Radiology, Professional Services, Pharmaceutical, Oncology, Technology, Data Analytics, Science, Biotechnology, Practice Management, Health, Newton, GE HealthCare, Data management, Partnership, Magnetic resonance, Medical journal, Signal-to-noise ratio, Workflow, Catalog, Neoplasm, Deep learning, RaySearch Laboratories, Cancer, GE, Hope, Intelligence, Immobilization, Doctor of Philosophy, Google Images, Congress, IRT, Patient, Patient safety, Risk, AIR, Oar, BMJ, Artificial intelligence, Diagnosis, Ecosystem, Yellow Sun (nuclear weapon), RT, European Society for Medical Oncology, FDA, Disease, Medical imaging

GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiation oncology care pathway.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiation oncology care pathway.
  • GE HealthCare worked closely with more than 150 clinicians globally, from community hospitals to leading healthcare institutions, to develop the new iRT platform which enables greater interoperability, connectivity, and efficiency throughout the entirety of the radiation oncology care continuum.
  • GE HealthCare is also streamlining the process of delineating organs at risk (OARs) with the introduction of Auto Segmentation.
  • To learn more about iRT, Auto Segmentation, AIR Open Coil Suite, and other GE HealthCare products , please visit our booth or gehealthcare.com .

BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

Retrieved on: 
Friday, May 12, 2023
Calendar, Diagnosis, Workflow, Gene editing, Research, Antibody, EDT, ISH, Bio-Techne, ELISA, Nature, Drug discovery, Cytokine, FDA, Conference, ACD, Prostate cancer, Cryptocurrency, Medical imaging

MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 2:35 p.m. EDT.

Key Points: 
  • MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 2:35 p.m. EDT.
  • A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar .
  • These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment.
  • With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022 and has approximately 3,000 employees worldwide.

RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at ESTRO 2023

Retrieved on: 
Friday, May 12, 2023
Cyberknife, Radiation, GE HealthCare, Face, Workflow, Accuray, Deep learning, RaySearch Laboratories, DICOM, GE, Patient, Hospital, Congress, GPU, Medical imaging, Retail

STOCKHOLM, May 12, 2023 /PRNewswire/ -- RaySearch will be showcasing the latest software innovations at ESTRO in Vienna, May 12-15.

Key Points: 
  • STOCKHOLM, May 12, 2023 /PRNewswire/ -- RaySearch will be showcasing the latest software innovations at ESTRO in Vienna, May 12-15.
  • Attendees will be able to book demonstrations of RayStation®* treatment planning system, RayCare®* oncology information system, and the cloud-based oncology analytics system RayIntelligence® during the congress.
  • The latest version of RayCare also offers improved connectivity and opportunity for seamless integration to other hospital information systems by the addition of new external interfaces.
  • RaySearch and Leo Cancer Care will do a joint presentation at RaySearch's booth #460, May 14, 1430 CET.

Global Container Shipping Track and Trace Solutions Market Report 2023 Featuring Top Competitors - P&O Ferrymasters, DP World, OPTEL Group, ORBCOMM, and ZIM

Retrieved on: 
Thursday, May 11, 2023
Radio, Pressure, ZIM, GPS, DP World, ORBCOMM, Workflow, History, RFID, Warehouse

DUBLIN, May 11, 2023 /PRNewswire/ -- The "Growth Opportunities for Track and Trace Solutions in the Global Container Shipping Sector" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 11, 2023 /PRNewswire/ -- The "Growth Opportunities for Track and Trace Solutions in the Global Container Shipping Sector" report has been added to ResearchAndMarkets.com's offering.
  • This study focuses on track and trace solutions used in the container shipping industry, specifically dry and reefer containers.
  • This study focuses on market definitions, sizes, forecasts, drivers, restraints, trends, competitors, and growth opportunities for the 2022-2029 study period.
  • The track and trace solutions for the container shipping market have tremendous growth potential.

Indee Labs Adopts Scispot to Operate as a Digital Biotech Company

Retrieved on: 
Thursday, May 11, 2023
Data management, Partnership, Medical University of South Carolina, Workflow, ELN, Stanford University, CFR, Medical school, Research, SOC, Electronic lab notebook, Automation, Immunotherapy, Bangladesh Technical Education Board, Social capital, Founders Fund, Indee Gold Mine, SOC 2, UCSF, Y Combinator, Laboratory information management system, Title 21 CFR Part 11, LIMS, Digital platform, HIPAA, D, Fine chemical

KITCHENER, ON, May 11, 2023 /PRNewswire-PRWeb/ -- Scispot, the creator of the best tech stack for modern biotech, announces its partnership with Indee Labs, the developer of Hydropore™ for non-viral intracellular delivery. This collaboration aims to empower Indee Labs to digitalize and centralize their research and development processes, leveraging Scispot's no-code operating platform for enhanced efficiency, compliance, and automation, enabling them to operate as a true Digital Biotech company.

Key Points: 
  • Transforming Biotech R&D: Indee Labs Leverages Scispot's Digital Platform for Enhanced Efficiency, Compliance and Automation
    KITCHENER, ON, May 11, 2023 /PRNewswire-PRWeb/ -- Scispot , the creator of the best tech stack for modern biotech, announces its partnership with Indee Labs, the developer of Hydropore™ for non-viral intracellular delivery.
  • This collaboration aims to empower Indee Labs to digitalize and centralize their research and development processes, leveraging Scispot's no-code operating platform for enhanced efficiency, compliance, and automation, enabling them to operate as a true Digital Biotech company.
  • With Scispot, Indee Labs and other Scispot customers can efficiently meet stringent compliance requirements, such as HIPAA, SOC 2, and CFR Part 11, ensuring a secure and compliant research environment.
  • "We're thrilled to partner with Indee Labs and support their innovative work in immunotherapy," said Guru Singh, founder & CEO of Scispot.

Global Lab Automation Market to 2035: Players Include Abbott, Anton Paar, BD, Beckman Coulter, ERWEKA, Leuze and Ortho Clinical Diagnostics

Retrieved on: 
Thursday, May 11, 2023
Nature, Workflow, University, Ortho Clinical Diagnostics, Research, USD, Time management, PerkinElmer, Siemens Healthineers, Instrument, Data analysis, Documentation, Laboratory, Risk, Roche, Eppendorf, Growth, Pall Corporation, ASRS, BD, Geography, Fine chemical, 3D printing, Typesetting, Warehouse, Mobile telephony, Automation, Tecan

This report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years.

Key Points: 
  • This report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years.
  • We believe that the lab automation market will grow significantly in the coming years, owing to significant advancements and the fact that lab automation and related modules can be customized to meet individual needs.
  • Answer: The global lab automation market is expected to grow at an annualized rate of 13% during the period 2023-2035.
  • As a result, increased reproducibility and precision are projected to drive the growth of the lab automation market.